24/7 Customer Support

+1 718 473 0872

The European Pharmaceutical Business

  • June 2012
  • 18 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

Refine your search results

Additional Related Reports

Pathology Description in Belgium and the US

  • Prevaccination Distribution of Human Papillomavirus Types in Wom...
  • September 2014
    11 pages
  • Pathology  

  • Belgium  

    United States  

View report >

Pathology Description in Egypt and Belgium

  • Impact of some Common Chronic Dermatoses on Quality of Life of E...
  • June 2014
    23 pages
  • Psoriasis  

    Acne  

  • Egypt  

    Belgium  

View report >

Pathology Description

  • Comparison of Cancer Patients Treated in Hospital Outpatient Dep...
  • November 2014
    40 pages
  • Cancer  

    Physician Offic...  

View report >

Pathology Description

2 months ago

Pathology Description

2 months ago

Pathology Description

3 months ago

Related Market Segments :

Cancer
Lung Cancer

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development ...

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market Summary GBI Research, a leading business intelligence ...


Related Market Segments :

Cancer
Lung Cancer
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.